Editorial: The use of Baveno VI and VII criteria for portal hypertension and varices in patients with hepatocellular carcinoma-Authors' reply.
作者信息
Allaire Manon, Thabut Dominique
机构信息
Service d'Hépato-gastroentérologie, AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Paris, France.
INSERM UMR 1138, Centre de recherche des Cordeliers, Paris, France.
出版信息
Aliment Pharmacol Ther. 2023 Aug;58(4):480-481. doi: 10.1111/apt.17648.
PMID:37499107
Abstract
摘要
相似文献
1
Editorial: The use of Baveno VI and VII criteria for portal hypertension and varices in patients with hepatocellular carcinoma-Authors' reply.
Aliment Pharmacol Ther. 2023 Aug;58(4):480-481. doi: 10.1111/apt.17648.
2
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
Aliment Pharmacol Ther. 2023 Aug;58(3):346-356. doi: 10.1111/apt.17599. Epub 2023 Jun 9.
3
The Baveno VI criteria to identify patients not requiring endoscopic surveillance for esophageal varices - Should we use it?
J Hepatol. 2017 Jun;66(6):1331-1332. doi: 10.1016/j.jhep.2017.01.035. Epub 2017 Mar 2.
4
Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages.
J Gastroenterol Hepatol. 2023 Aug;38(8):1381-1388. doi: 10.1111/jgh.16218. Epub 2023 May 22.
5
Editorial: The use of Baveno VI and VII criteria in patients with hepatocellular carcinoma.
Aliment Pharmacol Ther. 2023 Aug;58(4):478-479. doi: 10.1111/apt.17626.
6
Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Acta Gastroenterol Belg. 2022 Apr-Jun;85(2):321-329. doi: 10.51821/88.2.9553.
7
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
J Hepatol. 2016 Nov;65(5):899-905. doi: 10.1016/j.jhep.2016.06.021. Epub 2016 Jul 5.
8
Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria.
Curr Opin Gastroenterol. 2022 May 1;38(3):206-215. doi: 10.1097/MOG.0000000000000824. Epub 2022 Mar 2.
9
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology. 2019 Mar;156(4):997-1009.e5. doi: 10.1053/j.gastro.2018.11.053. Epub 2019 Feb 13.
10
Treatment of portal hypertension in patients with HCC in the era of Baveno VII.
J Hepatol. 2023 Mar;78(3):658-662. doi: 10.1016/j.jhep.2022.11.019. Epub 2022 Nov 30.
Zotero 插件